Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in Duchenne Muscular Dystrophy (SIDEROS)
NCT02814019Phase 3Terminated
- Sponsor
- Santhera Pharmaceuticals
- Start
- Sep 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of idebenone in Duchenne muscular dystrophy (DMD), sponsored by Santhera Pharmaceuticals. Started Sep 2016; status: terminated.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT02814019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814019.